Screener
Zymeworks ZYME Liability related to sale of future royalties
Liability related to sale of future royalties at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept zyme:AccruedSaleOfFutureRoyalties.
The source filing: Zymeworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001937653-26-000047
| Assets | June 30,2026 / (unaudited) | December 31,2025 |
|---|---|---|
| Total current liabilities | 47,243 | 42,318 |
| Long-term portion of operating lease liability | 12,703 | 14,796 |
| Deferred revenue | — | 14,606 |
| Liability related to sale of future royalties | 252,631 | — |
| Other long-term liabilities | 278 | 278 |
| Deferred tax liability | 3,740 | 6,028 |
| Total liabilities | 316,595 | 78,026 |
| Stockholders’ equity: |
Item 1. Financial Statements
FAQ
- What is Zymeworks's liability related to sale of future royalties?
- Zymeworks (ZYME) reported liability related to sale of future royalties of $252.63M in Q2 2026.
- What does liability related to sale of future royalties mean?
- Liability related to sale of future royalties as reported by Zymeworks Inc..
Ask your AI about Zymeworks's liability related to sale of future royalties.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude